Therapeutic Challenges for Cisplatin-Resistant Ovarian Germ Cell Tumors

The majority of patients with advanced ovarian germ cell cancer are treated by cisplatin-based chemotherapy. Despite adequate first-line treatment, nearly one third of patients relapse and almost half develop cisplatin-resistant disease, which is often fatal. The treatment of cisplatin-resistant dis...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Prif Awduron: Ugo De Giorgi, Chiara Casadei, Alice Bergamini, Laura Attademo, Gennaro Cormio, Domenica Lorusso, Sandro Pignata, Giorgia Mangili
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: MDPI AG 2019-10-01
Cyfres:Cancers
Pynciau:
female patients
germ cell tumors
ovarian germ cell tumors
salvage therapy
refractory
high-dose chemotherapy
Mynediad Ar-lein:https://www.mdpi.com/2072-6694/11/10/1584
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg